Live
Merck KGaAMerck KGaA Backs Hybrid Cancer Drugs And Greener Lab Consumables - simplywall.stBioPharma DiveArvinas’ ‘Protac’ breast cancer drug cleared by FDAClinical OMICsData-Driven Tool Identifies Individuals at Highest Risk of Obesity-Related DiseaseClinical OMICsMachine Learning Tool Helps Improve Type 1 Diabetes PredictionClinical OMICsPatient-Derived Lab-on-a-Chip Improves Precision Modeling of Pancreatic CancerClinical OMICsCitraconate Enhances Antitumor Activity and Reduces Exhaustion in T CellsEndpoints NewsModerna in talks with FDA over Phase 4 Covid vaccine dataBio-RadBio-Rad Weighs 2026 Outlook As Middle East Headwinds Meet Stilla Hopes - simplywall.stEndpoints NewsFDA approves Pfizer and Arvinas' breast cancer drug despite underwhelming dataModernaModerna’s first quarter 2026 sales well ahead of estimates - The Pharma LetterEndpoints NewsAmgen launches late-stage obesity trial in patients who switch from rival drugsFierceBiotech‘M&A used to be the only way to go’: Why Seaport’s CEO opted for route to upsized $255M IPO

Archive

Latest Oldest
Total 9886
Page 241 / 550
Query --